Related Experiment Video
Updated: Mar 29, 2026

12:03
Fertility Preservation in Patients with Severe Ovarian Dysfunction
Published on: March 25, 2021
5.2K
Fertility issues in patients with hematologic malignancies.
1Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA.
Hematology. American Society of Hematology. Education Program
|December 6, 2015
Summary
Cancer patients need early discussion of fertility preservation options. Hematologic malignancy patients may require unique oncofertility strategies and specialized care coordination for improved quality of life and parenthood prospects.
Area of Science:
- Oncology
- Reproductive Medicine
- Hematology
Background:
- Cancer treatment can pose significant risks to reproductive health and fertility.
- Discussing fertility preservation with newly diagnosed cancer patients is crucial for comprehensive care.
- Standard fertility preservation methods exist, but options for pre-pubertal children are experimental.
Purpose of the Study:
- To highlight the importance of addressing reproductive health in cancer care.
- To discuss fertility preservation challenges and alternative strategies in hematologic malignancy patients.
- To emphasize the need for expedited communication between oncologists and reproductive specialists.
Main Methods:
- Review of standard fertility preservation techniques (embryo/oocyte cryopreservation, sperm banking).
- Exploration of unique approaches for hematologic malignancy patients, including experimental techniques.
- Discussion of post-treatment referrals and management strategies like hormonal therapy or medication discontinuation.
Main Results:
- Standard fertility preservation options may be challenging for patients with hematologic malignancies.
- Alternative and experimental strategies are being explored for this distinct patient population.
- Expedited communication and facilitated referrals significantly enhance patient care and outcomes.
Conclusions:
- Addressing fertility is an essential component of comprehensive cancer care.
- Specialized approaches and interdisciplinary collaboration are vital for hematologic malignancy patients.
- Further research in oncofertility, particularly for hematologic malignancies, is needed to improve survivor parenthood prospects.
More Related Videos
Related Concept Videos
Infertility in Males
682
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
682
Infertility in Females
5.0K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
5.0K
Bone Marrow Sampling and Transplants
2.4K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.4K
Regulation of Hematopoietic Stem Cells
4.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K
Stem Cell Therapy for Tissue Regeneration
4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
Spermatogenesis
124.7K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
124.7K

